A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) - No Study Results Posted

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (ENEST)

This study is ongoing, but not recruiting participants.

Study NCT00471497 Information provided by Novartis

First Received: May 7, 2007 Last Updated: March 27, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2013 (Final data collection date for primary outcome measure)